NUCB2/nesfatin-1 is associated with severity of eating disorder symptoms in female patients with obesity

dc.contributor.author	Stengel, Andreas
dc.date.accessioned	2022-11-21T10:55:31Z
dc.date.available	2022-11-21T10:55:31Z
dc.date.issued	2022
dc.identifier.issn	0306-4530
dc.identifier.uri	http://hdl.handle.net/10900/133225
dc.language.iso	en	de_DE
dc.publisher	Pergamon - Elsevier Science Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.psyneuen.2022.105842	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	NUCB2/nesfatin-1 is associated with severity of eating disorder symptoms in female patients with obesity	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_00034
utue.personen.roh	Weibert, Elena
utue.personen.roh	Hofmann, Tobias
utue.personen.roh	Elbelt, Ulf
utue.personen.roh	Rose, Matthias
utue.personen.roh	Stengel, Andreas
dcterms.isPartOf.ZSTitelID	Psychoneuroendocrinology	de_DE
dcterms.isPartOf.ZS-Issue	Article 105842	de_DE
dcterms.isPartOf.ZS-Volume	143	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE

Files in this item

Files	Size	Format	View
There are no files associated with this item.